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Abstract 
L’acido sulfidrico (H2S) è stato considerato per lungo tempo come un gas 
tossico, ma recentemente i suoi effetti farmacologici sono stati rivalutati. E’ stato 
dimostrato che tale mediatore è prodotto in vari tessuti grazie all’azione di due enzimi 
quali cistationina-γ-liasi (CSE) e cistationina-β-sintasi (CBS), ed è coinvolto in vari 
processi fisiopatlogici. In particolare da questi studi emerge per l’acido sulfidrico un 
ruolo di primo piano nella regolazione dell’omeostasi vascolare e nei processi 
infiammatori. E’ noto, infatti, che H2S induce vasodilatazione mediante interazione con 
i canali del potassio ATP-dipendenti (K+ATP) e che una riduzione dei livelli plasmatici 
di H2S rappresenta un fattore che contribuisce allo sviluppo dell’ipertensione 
spontanea. Viceversa, in stati infiammatori ed in particolare in seguito a 
somministrazione di LPS nei topi, si riscontra un aumento dei livelli plasmatici di tale 
mediatore gassoso. 
Queste evidenze hanno portato alla volontà di studiare il ruolo di H2S nel 
compartimento vascolare ed in particolare in che modo esso possa interagire con 
l’endotelio e con i mediatori da esso prodotti, quali ad esempio il monossido d’azoto 
(NO) nella regolazione dell’omeostasi vascolare e quindi anche dei processi 
infiammatori. Pertanto, è stato utilizzato un primo approccio di tipo funzionale allo 
scopo di indagare sul coinvolgimento di tale molecola in un modello di disfunzione 
vascolare associato al diabete mellito insulino-dipendente (IDDM), utilizzando aorte 
espiantate da animali spontaneamente diabetici (NOD/Ltj). 
E’ da sottolineare il fatto che in questi animali la disfunzione endoteliale è 
principalmente legata ad una drastica riduzione dei livelli di NO. Il passo successivo è 
stato poi caratterizzato da uno studio molecolare mirato alla valutazione 
dell’espressione degli enzimi responsabili della sintesi di H2S e alla quantificazione 
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della produzione di tale mediatore. In ultima analisi, è stato poi valutato il ruolo di H2S 
nella regolazione della risposta infiammatoria, utilizzando diversi modelli animali e 
cellulari. 
I primi risultati ottenuti hanno mostrato un chiaro coinvolgimento di NO nella 
vasodilatazione indotta da H2S, in particolare NO sembra regolare positivamente la 
produzione enzimatica di H2S a partire da L-cisteina, suo precursore endogeno, 
mediata da CBS e CSE. Inoltre, lo studio condotto sugli animali diabetici evidenzia una 
riduzione della capacità vasodilatante della L-cisteina, sintomo di un’alterata attività 
enzimatica probabilmente correlata ai ridotti livelli di NO. 
Lo studio molecolare effettuato attraverso analisi di western blot e qRT-PCR ha 
mostrato un aumento nella espressione di CBS e CSE, sebbene i livelli di H2S 
plasmatici e tissutali siano significativamente ridotti negli animali diabetici. Ciò 
potrebbe essere ascrivibile ad un fenomeno di tipo compensatorio in risposta ad una 
riduzione dei livelli di H2S circolanti. 
Infine, i risultati ottenuti attraverso l’utilizzo di diversi modelli animali di 
infiammazione hanno mostrato che H2S è in grado di inibire la migrazione dei 
polimorfonucleati (PMN) nei tessuti in seguito a stimolazione con agenti flogogeni; in 
particolare, questa azione è mediata dai canali del potassio ATP-dipendenti. Inoltre, 
l’edema indotto da carragenina veniva significativamente ridotto dal trattamento con 
diversi donatori di H2S. 
In conclusione i risultati sperimentali ottenuti indicano in primo luogo che 
l’ossido nitrico è coinvolto nei meccanismi di vasodilatazione indotti da H2S, 
suggerendo l’esistenza di un legame tra le vie metaboliche L-arginina/NO e L-
cisteina/H2S nella regolazione del tono vascolare. Inoltre, H2S mostra un effetto anti-
infiammatorio, che si esplica principalmente attraverso il blocco della migrazione 
 - 9 -
leucocitaria. Queste evidenze, nel loro insieme, suggeriscono per la prima volta che 
H2S agisce in maniera diretta sulle cellule endoteliali vascolari influenzando molteplici 
fenomeni che avvengono all’interfaccia tra endotelio e sangue, in particolare 
intervenendo sul mantenimento dell’omeostasi vascolare e sulla regolazione della 
migrazione leucocitaria. 
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Summary 
Sulphidric acid has been considered for a long time just a polluting gas and only 
recently its pharmacological effects have been investigated. H2S is produced in many 
mammalian tissues by two enzymes, cystathionine-γ-lyase (CSE) and cystathionine-β-
synthase (CBS) and it is involved in many physiological and pathological events. In 
particular this gas seems to have a critical role in vascular homeostasis and in 
inflammatory processes. It has been demonstrated that H2S induces K+ATP channels-
dependent vasorelaxation and that spontaneous hypertension is associated to its 
lowered plasmatic levels. On the other hand, during inflammatory process, such as LPS 
administration in mice, plasmatic H2S levels result increased. 
These evidences put us on way to investigate the role of H2S in vascular tone 
regulation and the possible relationship with nitric oxide (NO). Furthermore the aim of 
this work was also to assess involvement of this gaseous molecule in inflammatory 
events. For these reasons, we first used a functional approach in order to study H2S role 
in a model of endothelial dysfunction associated to diabetes, by using aortic tissue 
harvested from Non ObeseDiabetic mice (NOD/Ltj). These animals show endothelial 
disorder mainly associated to a reduction  in NO levels. 
The following step was characterized by a molecular  approach in order to 
verify the expression of CBS and CSE and their enzymatic activity leading to H2S 
production. The last part of this work dealt with evaluation of hydrogen sulphide in 
inflammatory responses. First data obtained showed a marked involvement of NO in 
H2S-induced vasodilatation and in particular NO seemed to regulate production of H2S 
from L-cysteine, its biological precursor. Furthermore, results of experiments carried 
out on diabetic mice highlighted a reduce vasodilatory effect by L-cysteine, likely linked 
to reduced NO availability. Molecular data showed that both CBS and CSE expression 
 - 11 -
are significantly increased, although plasmatic levels of H2S were reduce in diabetic 
mice. This evidence could reflect a compensatory response  in order to restore H2S 
levels. 
Finally, data obtained from experiments performed on different animal model of 
inflammation clearly demonstrated that H2S inhibited polymorphonuclear (PMN) 
transmigration, following an inflammatory stimulus. In addition, this effect is mediated 
by K+ATP channels. 
In conclusion, our experimental data indicate for the first time that nitric oxide 
is involved in vasodilatory effect induced by H2S, suggesting a link between L-
arginine/NO and L-cysteine/H2S pathway in vascular tone regulation. 
Furthermore, hydrogen sulphide showed an anti-inflammatory effect, mainly 
exerted through blockade of PMN transmigration. Altogether, these evidences suggest 
that H2S is able to act directly on endothelial cells, where it is also produced, affecting 
all phenomenon occurring at blood-endothelium interface, particularly intervening on 
maintenance of vascular homeostasis and regulation of leukocytes migration. 
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CHAPTER 1 
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1. INTRODUCTION 
 
In the second century A.D. Galen said: “Throughout the body the animal 
arteries are mingled with veins and veins with arteries, and both veins and arteries are 
mingled with nerves and the nerves with these…And of course the usefulness of such a 
complete interweaving is very evident, if, that is to say, it is a useful thing for all parts 
of the animal to be nourished”. Then, in despite of a very sophisticated and fine 
regulated human body, the most important and easy way for maintaining it alive and 
well working in all its functions is just represented by blood. Its flowing through a 
massive network of  “tubes” makes all cells being fed with all nutrients needed and keep 
in constant communication all organs and tissues, even if they are far away from each 
other. In this kind of processes , these “tubes”, called vessels, are simply fundamental 
(fig. 1.1) 
Vessels are divided into two main categories, such as arteries and veins. Both of 
them have a particular structure formed by three layer of different cells types, even if 
there are some quantitative differences. The outer one is represented by adventitia, 
mainly formed by collagen and fibroblasts; in the middle, there is the media, constituted 
by smooth muscle cells; finally, the inner layer is the endothelium, formed by a 
monolayer of endothelial cells that have a proper direct contact with all molecules going 
around the body through the blood flow (fig. 1.2). The possibility of this interface 
contact between endothelium and blood makes the endothelium one of the most 
important actor in regulating physiology of vascular tone; and this also because it 
actually represents a “barrier” allowing or not molecules passing through it and going 
into tissues, and then exerting their own effects. 
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The activity of this “barrier” is regulated at various levels by a wide range of 
molecules but for sure the one playing a pivotal role is nitric oxide (NO). Through 
years, NO and its effects have been described in details and its scenario has been well 
drawn up (Palmer RM et al., 1988; Moncada S et al., 1991). Particularly, it has been 
appearing clear how just one simple molecule like NO could be responsible for vascular 
relaxation, pro-inflammatory actions and proliferation affecting stimuli (Cirino G et al., 
2003; Garcia X et al., 2006; Moncada S et al., 1991). Furthermore, alteration of  NO 
levels is consistent with many pathological conditions, overall endothelial dysfunction 
(Nagareddy PR et al., 2005; Bucci M et al., 2004; Pechanova O et al., 2007). 
In this contest, another important gaseous mediator has been recently 
considered: the gaseous molecule in question is hydrogen sulphide (H2S). H2S has been 
known since early times and its chemistry has been studied since the 1600s; it is a 
colourless gas with a typical rotten eggs smell that represents the main reason it is well 
known for. This molecule was thought just like a toxic and polluting gas for a long time, 
even if pollution was later discovered to occur at concentration 400-fold higher than 
physiological one. Only in last decade its involvement in many physiological and 
pathological processes has been found out, and the aim of  this work is just to assess its 
functions, contributing to the latest findings in the “pharmacology of hydrogen 
sulphide”. 
. 
 - 15 -
Fig. 1.2 Structure of blood vessels. Arteries and veins are a complex of 
multiple layers where endothelium represents the inner one and smooth 
muscle cells and connective tissue are stratified over it 
Fig. 1.1 Medieval images of circulatory tree 
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1.1 THE ENDOTHELIUM AS A DETECTOR INDUCING VASCULAR CHANGES 
 
1.1.1 Vascular endothelium and its multi-functional role 
 
 The endothelium is a specialized type of epithelial tissue consisting in a thin 
layer of cells that line the interior surface of blood vessels and forming an interface 
between circulating blood in the lumen and the rest of the vessel wall. In all types of 
blood vessels the endothelium of the tunica intima is highly specialised with endocrine, 
exocrine, cell adhesion, clotting and transport functions. Endothelial cells line the entire 
circulatory system, from the heart to the smallest capillaries and they reduce friction of 
blood flow allowing the fluid to be pumped further. 
Endothelium is composed of flattened cells and in routine histological sections 
the cytosol of most cells is barely visible and only the small flattened nuclei are seen. 
Ultrastructurally, each cell can be seen to be anchored to an underlying basal lamina; 
individual cells are anchored together by adherent junctions, including prominent tight 
junctions which prevent diffusion between cells.  
A major feature of endothelial cells is represented by pinocytotic vesicles which 
are involved in the process of transport of substances from one side of the cell to the 
other. In small blood vessels of the nervous system, endothelial cells express transport 
proteins which are responsible for active transport of all substances, for example 
glucose into the brain. Furthermore, they are able to sense changes in blood pressure, 
oxygen tension and blood flow by as yet unknown mechanisms. In response to changes 
in local conditions they respond by secreting substances which have powerful effects on 
the tone of vascular smooth muscle. Endothelium is also important in the control of 
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blood coagulation, since under normal circumstances its surface prevents blood clotting 
and allows a smooth blood flux (Santiago-Delpin EA, 2004; Ppova EN et al., 2004). 
Another important feature of endothelium is characterized by its ability in 
adapting rapidly to changes in its environment. In fact, under certain circumstances, 
especially in response to adverse stimuli such as wounds, infections or irritation (e.g. 
insect sting), it becomes activated and changes its function (Pober JS et al., 2002). This 
activation is mainly operated by cytokines and develops specialisation for lymphoid 
cells migration. The endothelial cells become cuboidal in shape and express surface 
adhesion molecules which facilitate lymphocytes adhesion and migration. This type of 
endothelium is particularly present in the specialised venules in the lymph node 
paracortex (high endothelial venules). These changes normally occur after tissue 
damages and allows neutrophils to migrate into local tissues during acute inflammation. 
One of the first step in this pathway is represented by exposure of P-selectin, a cell 
adhesion molecule stored in special vesicles (Weibel-Palade bodies) inside the 
endothelium. Upon an appropriate stimulation, these vesicles dock with the endothelial 
cell membrane and P-selectin is then available on the cell surface for neutrophils 
adhesion (Arribas M et al., 2000; Burns AR et al., 1999) (fig. 1.3).  
In physiological conditions, endothelium is locally impermeable to substances 
circulating in the blood but in presence of certain molecules, such as histamine, they 
lose attachment to each other and retract. This change allows fluid and proteins to 
diffuse out into local tissues causing its swelling, termed oedema. The reorganisation of 
cell-cell junctions is rapid and reversible and takes place in the space of a few minutes 
(Tab I).  
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 Tab 1 - Properties of endothelial cells of blood vessels      
                    
a) Cells are bound together by junctional complexes and have many pinocytic vesicles 
b) Cells, although simple in appearance, have many complex roles 
c) Under normal circumstances secretes substances which prevent blood clotting 
d) 
Also under normal circumstances secretes substances which maintain the tone of vascular 
smooth muscle 
e) 
Can be activated by cytokines to express cell adhesion molecules which allow white blood 
cells to stick 
Fig 1.3 P-selectin and E-selectin are involved in rolling of circulating 
leukocytes and in transmigration process in inflamed tisues 
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1.1.2 Endothelial cells in the regulation of vascular tone 
 
Arterial blood pressure is mainly regulated by a tight balance between different 
molecules having vasoconstrictor and vasorelaxant activities Pechanova O et al., 2007). 
Since endothelium represents a proper barrier between blood and tissues, it actually is 
the first element which comes in contact with all circulating molecules and it is also 
able to counteract any kind of misbalancing events. Endothelial cells produce and/or 
release a wide range of molecules responsible for regulation of vascular tone (Tab II). 
An alteration in production or release of these mediators could lead to an endothelial 
dysfunction, a hallmark for vascular diseases, typically associated to diabetes and 
hypertension (Bucci M et al., 2004; Li J et al., 2007; Punthakee Z et al., 2007). 
One of the most important factor produced by endothelium is NO, released by 
enzymatic degradation of L-arginine operated by the endothelial isoform of nitric oxide 
synthase (eNOS). This radicalic molecule activates the soluble guanylate cyclase (sGC), 
increasing the amount of cGMP and leading to the final effect consisting in relaxation 
of smooth muscle cells. Furthermore, NO-dependent pathway activates cGMP-
dependent protein kinase (PKG) that acts through opening potassium (K+) channels and 
externalization of K+ ions outside the cell. NO is extremely important in this 
environment since, its impaired release is associated to endothelial dysfunction (fig 
1.4a). 
Another important mediator involved in homeostasis of vascular tone is 
prostacyclin (PGI2). As NO, also PGI2 exerts vasorelaxant activity but through a 
different mechanism. Indeed, it activates adenylate cyclase and induces an increase in 
cAMP levels. Its increase activates PKA, a cAMP-dependent protein kinase,  that in 
turn induces opening of  K+ channels PKG (fig 1.4b). 
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Belong vasoconstrictor mediators released by endothelium, there are endothelins 
(ETs). Endothelin-1 (ET-1), a peptide of 21 amino acid residues, is the most potent 
vasoconstrictor substance known. Originally isolated from porcine aortic endothelial 
cells, 
  
Fig 1.4 a) Nitric oxide signalling in vascular tissue. NO diffuses from 
endothelium to smooth muscle cells and there activate soluble guanylate 
cyclase, increasing production of cGMP that leads to vasorealxation. b) PGI2 
signalling in vascular tissues. PGI2 activates adenylate cyclase increasing 
release of cAMP, responsible for relaxation through PKA activation. 
a) 
b) 
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ET-1 is now known to belong to a family of three mammalian vasoactive peptides that 
also includes endothelin-2 (ET-2) and endothelin-3 (ET-3). ETs have a double effect 
depending upon activation of two different receptors, ETA and ETB. Both receptors are 
expressed on smooth muscle cells and binding of ETs on these receptors is able to 
induce vasoconstriction. Conversely, only ETB is expressed on endothelial cells and its 
activation leads to vasodilation via NO production (Rubanyi GM et al., 1994; Luscher T 
et al., 2000; Suzaki Y et al., 2003) (fig 1.5a). 
 All mediators, so far mentioned, are just a part of the very complex network of 
molecules underlying the regulation of vascular functions and it has to be said about the 
existence of a neural system capable to interplay with NO, PGI2 and ETs. In this 
network a prominent role is occupied by sympathetic system supplying hormones like 
noradrenalin and adrenalin, the major neuropeptides released upon nervous fibers 
activation. 
 In addition, it is noteworthy to underline the activity of the renin-angiotensin 
system and of vasopressin responsible, in association with ETs, of the constrictor effects 
in complex equilibrium that leads to the vascular homeostasis (fig 1.5b). 
 
 
Tab II - Molecules produced by endothelial cells 
  
Factor secreted by the endothelium Activities 
Prostacylin (PGI2) vasodilation, inhibits platelet aggregation 
Nitric Oxide (NO) vasodilation, inhibits platelet adhesion and aggregation 
Tissue Plasminogen Activator (tPA) regulates fibrinolysis 
thrombomodulin anticoagulant activity 
thromboplastin promotes blood coagulation 
Platelet Activating Factor (PAF) activation of platelets and neutrophils 
von Willebrand Factor (vWF) promotes platelet adhesion and activation of blood coagulation
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Fig 1.5 a) Endothelins signalling pathway. ETs have both constrictor and 
relaxant effects, depending upon activating ETA or ETB receptor. b) Balancing  
and interplay of vasoactive molecules in vascular tissue. 
a) 
b) 
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1.1.3 Inflammation and endothelial cells: interplay and communication 
 
 An inflammatory condition is characterized by a wide range of events one of 
which is the leukocyte transmigration. This event starts following an injury generating 
activation and release of cytokines by macrophages (IL-1, TNF-α), that in turn induce 
the expression of selectins (P- and E-selectin) on endothelial cell surface. Together P- 
and E-selectin slow the motion of leukocytes through the bloodstream by causing them 
to roll along the endothelial surface, allowing other molecules to interact with the 
slowed leukocytes in order to stop them and to promote their movement into the tissues 
(Leeuwenberg et. al. 1992). Leukocyte rolling occurs due to the brief, reversible binding 
of E and P-selectin with their complementary molecules, which are expressed on the 
surface of leukocytes. 
At the same time, chemokines released by macrophages activate the rolling 
leukocytes and cause activation of integrins, another type of adhesion molecules. This 
activation consists in switching leukocytes from the default low-affinity state to a high-
affinity state. This is assisted by juxtacrine activation of integrins by chemokines and 
soluble factors released by endothelial cells. In the activated state, integrins bind tightly 
to complementary receptors expressed on endothelial cells, with high affinity. The 
overall effect is the immobilization of the leukocytes, despite the shear forces of the 
ongoing blood flow (Aplin AE et al., 1998). 
In order to migrate the cytoskeleton of the leukocytes is re-organized in such a 
way that the leukocytes are spread out over the endothelial cells. In this form, 
leukocytes extend pseudopodia and pass through gaps between endothelial cells. 
Transmigration of the leukocytes occurs as PECAM proteins, found on the leukocyte 
and endothelial cell surfaces, interact and effectively pull the cell through the 
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endothelium. The leukocytes secrete proteases that degrade the basement membrane, 
allowing them to escape the blood vessel – a process known as diapedesis. Once in the 
interstitial fluid, leukocytes migrate along a chemotactic gradient towards the site of 
injury or infection and become ready to counteract the inflammatory events (fig. 1.6). 
Acute inflammation normally resolves by mechanisms that have remained 
somewhat elusive. Emerging evidence now suggests that an active, coordinated 
program of resolution initiates in the first few hours after an inflammatory response 
begins. After entering tissues, leukocytes promote the switch of arachidonic acid–
derived prostaglandins and leukotriens of the starting phase of inflammation to lipoxins, 
which initiate the termination sequence. Belonging to this class of protein, we find 
Annexin 1 (AnxA1), well known as Lipocortin-1 too; this protein is playing a critical 
role in endothelial transmigration of neutrophils, being activated and exposed on cell 
surface once inflammation starts. In particular, it blocks adherence of leukocytes and 
diapedesis, promoting an anti-inflammatory effect (Kamal H. et al., 2005) (fig. 1.7). 
Thus, when neutrophil recruitment ceases, programmed death by apoptosis is 
engaged and this event coincides with the biosynthesis of resolvins and protectins 
(Serhan CN et al., 2005). Then, apoptotic neutrophils undergo phagocytosis by 
macrophages, leading to neutrophil clearance and release of anti-inflammatory and 
reparative cytokines such as transforming growth factor-β1 (TGF-β1). The anti-
inflammatory program ends with the departure of macrophages through the lymphatics. 
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Fig 1.6 Rolling of leukocytes onto endothelial cells surface represents the first 
step of diapedesis. Then, leukocytes tightly adhere to adhesion molecules and 
changes in shape occur, allowing them to go through endothelium towards tissue.  
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Fig 1.7 The concept of resolution and inflammatory pathology. This scheme 
summarises the concept behind the study of antiinflammation. It is proposed that the 
physiological scenario (1) is observed when a pro-inflammatory phase of 
inflammation is followed by an active phenomenon of resolution. Inflammatory 
pathology could be due to an overshooting of the pro-inflammatory phase (2) or by a 
lack of active resolution, with consequent prolongation of the inflammatory aetiology 
and symptoms (3). It is worth noting that scenario no. 2 could also due, at least in 
part, by lack of activity of anti-inflammatory mediators, tonically active to down-
regulate the pro-inflammatory phase (classical example being the one of  
glucocorticoids, in view of the exacerbation of the response observed after 
adrenalectomy) (Flower RJ et al. 1986, Perretti M et al. 1989). 
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1.2 HYDROGEN SULPHIDE (H2S): GASEOUS CHEMICAL WITH BIOLOGICAL 
ACTIVITIES 
 
1.2.1 H2S: an overview on chemical and biochemical properties 
 
H2S structure is very similar to that of water and this is where the similarity ends 
(fig 1.8). The sulphur atom is not nearly as electronegative as oxygen so that hydrogen 
sulphide is not nearly as polar as water.  Because of this, comparatively weak 
intermolecular forces exist for H2S and the melting and boiling points are much lower 
than they are in water.  In fact, boiling temperature of hydrogen sulphide and water are -
60.7 °C and +100.0 °C , respectively. 
 
 
 
 
 
 
 
 
Hydrogen sulphide is weakly acidic, dissociating in aqueous solution into 
hydrogen cations H+ and the hydrosulphide anion HS-, which subsequently may 
decompose to H+ and sulphide ion S2- (Ka1 = 1.3x10-7 M, Ka2 =1x10-19 M; Giggenbach 
W, 1971; Myers RJ, 1986). 
 
 H2S HS-H+ H+ S2-+ +
Ka1 Ka2
Fig 1.8 Similarity in molecular structure between water (H2O) and hydrogen sulphide (H2S) 
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Under physiological conditions, i.e. at pH 7.4, one third of hydrogen sulphide is 
undissociated and this means that more than 30% of  this gas may be revealed in 
biological fluids as H2S. Conversely, the chemical form S2- is not present in appreciable 
amounts, since the dissociation of HS- occurs only at high pH values. 
In a similar way to other biological relevant gases like carbon monoxide (CO) 
and nitric oxide (NO), H2S has lipophilic features that confer on it the capability to 
permeate plasmamembrane. Nevertheless, due to partial dissociation, membrane are 
relatively less permeable to H2S than to both other gases. 
 In mammalian, the “smelling gas” is endogenously produced by enzymatic 
reactions, even if some non-enzymatic pathways are involved in biochemistry of 
hydrogen sulphide. Enzymes regulating its release are cystathionine-β-synthase (CBS) 
and cystathionine-γ-lyase (CSE) that work differently but both have a key role in H2S 
metabolic pathway (Chen X et al., 2004). However, the only substrate for the generation 
of endogenous H2S from these enzymes is L-cysteine, a sulphur-containing amino acid 
derived from alimentary sources, synthesized from L-methionine through a so called 
“trans-sulfuration pathway” with homocysteine (Hcy) as an intermediate, or liberated 
from endogenous protein (Meier M et al., 2001; Yap S et al., 2000) (fig 1.9). 
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Fig 1.9 Endogenous hydrogen sulphide synthesizing pathways. Homocysteine is the 
physiological substrate for CBS, that in presence of cysteine releases both H2S and 
cystathionine. Cystine and cystathionine are both substrate for CSE, that is able to 
produce both cysteine and thiocysteine; the latter releases H2S in a non-enzymatic way 
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  Another pathway that leads to the release of H2S is represented by a 
“desulfhydration” reaction, consisting in the removal of cysteine sulphur atom without 
its oxidation and this process may be catalyzed by both trans-sulfuration pathway 
enzymes, CBS and CSE. On the other hand, H2S catabolic pathway is not well defined 
yet, and most of the data we have been  obtained by using exogenous H2S; this implies 
that most of the studies carried out till now may not have biological and physiological 
relevance. Hydrogen sulphide is rapidly oxidized, mainly in mitochondria, initially to 
thiosulfate which is further converted to sulphite and sulphate. This oxidation is not 
enzymatically driven, whilst thiosulfate conversion in sulphate and/or sulphite is 
catalyzed by thiosulfate-cyanide sulfurtransferase (TST).  
Also, sulfite originated by this reaction is quickly oxidized to sulphate, as 
sulphate is the major end-product of H2S metabolism under physiological conditions; 
however urinary thiosulfate is considered to be an aspecific marker of whole-body H2S 
production (Belardinelli MC et al., 2001). 
Another catabolic pathway is represented by methylation by thiol-S-
methyltransferase (TSMT) to methanethiol and dimethylsulfide. This reaction occurs 
mainly in cytosol and some studies question the significance of this pathway in  the 
gastrointestinal tract (Levitt MD et al., 1999; Picton R et al., 2002). Finally, hydrogen 
sulphide is able to bind to methaemoglobin to form sulfhaemoglobin and since 
haemoglobin may also bind CO and NO, it is considered a “common sink” for all three 
endogenous gases (Kurzban GP et al., 1999) (fig 1.10) 
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a) 
b) 
c) 
Fig 1.10 Catabolism of H2S. a) mytocondrial oxidation; b) cytosolic methylation; c) 
bindind to haemoglobin. SO: sulfite oxidase; TMST: thiol-S-methyl transferase; TST: 
thisulfate-cyanide sulfurtransferase (rhodanese) 
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1.2.2 H2S producing enzymes cystathionine-β-synthase (CBS) and cystathionine-γ-lyase 
(CSE) 
 
 H2S formation is related to the activity of both cystathionine-β-synthase (CBS), 
and cystathionine-γ-lyase (CSE), two pyridoxal-5’-phosphate(PLP)-dependent enzymes 
involved in trans-sulfuration pathway that differ in their specific mechanism (fig 1.9). 
CSE, also known as cystathionase (CTH), is mainly able to convert 
cystathionine in cysteine; basically, it also catalyses elimination reactions of L-
homoserine to form H2O, NH3 and 2-oxobutanoate, of L-cystine, producing thiocysteine, 
pyruvate and NH3, and of L-cysteine producing pyruvate, NH3 and H2S (Braunstein AE 
et al., 1950; Braunstein AE et al., 1952;  Flavin M et al., 1964). CSE is a protein of 
405aa and it structurally is a tetramer formed by two homodimers both contributing to 
the active site pocket (fig 1.11a). 
On the other hand, CBS is a cystathionine forming enzyme even if, in general, it 
catalyses β-replacement reactions between L-serine, L-cysteine, cysteine thioethers, or 
some other β-substituted α-L-amino acids, and a variety of mercaptans (Braunstein AE 
et al., 1971; Nakagawa H et al., 1968; Schlossmann K et al., 1962). In case that 
condensation reaction involves cysteine and homocysteine, the final product will be H2S 
as well as cystathionine. The human CBS is a homotetramer consisting of 63 kDa 
subunits, which binds two cofactors, pyridoxal-5’-phosphate (PLP) and heme (Skovby 
et al., 1984; Kery et al., 1994). Each CBS subunit of 551 amino acid residues binds two 
substrates (homocysteine and serine) and is further regulated by S-adenosyl-L-
methionine (AdoMet) (Kery et al., 1994). While the role of heme in CBS is unknown, 
catalysis by CBS can be explained solely by participation of PLP in the reaction 
mechanism (Kery et al., 1999) (fig 1.11b). 
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 From a biological point of view, one thing to be considered is that CSE seems is 
described as the major H2S-generating enzyme in cardiovascular system, while CBS is 
mainly involved in central nervous system (CNS) (Wang R, 2002). However, the 
presence of both enzymes could be required for producing H2S in some tissues. Thus, it 
comes as no surprise that the expression of CBS and CSE is tissue specific. The 
expression of CBS (Hosoki R et al., 1997; Meier M et al., 2001) and CSE (Levonen AL 
et al., 2000; Lu Y et al., 1992; van der Molen EF et al., 1997) has been identified in 
many human and other mammalian cells; indeed, both were found in liver, kidney, 
brain, fibroblast and blood cells, and their activity is regulated by H2S-dependent 
negative feedback mechanism since H2S, the end product of cysteine metabolism, 
blocks CBS and CSE. 
Furthermore, other regulatory mechanisms intervening in this pathway should be 
still clarified, although nitric oxide has already been shown upregulating CSE 
expression in smooth muscle cells in certain conditions (Sheng L et al., 2006; Zhang Y 
et al., 2005). 
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   a) 
 
 
 
 
 
 
 
 
 
   b) 
 
 
 
 
 
 
Fig 1.11 a) Cystathionine-γ-lyase (CSE) molecular structure. Red circles evidence 
pyridoxal-5’-phosphate (PLP) residues in quaternary folding of enzyme. b) Cystathionine-β-
synthase (CBS) molecular structure. Red circles show pyridoxal-5’-phosphate (PLP) 
residues and yellow circles highlight the position of heme-groups. 
Pyridoxal-5’-phosphate (PLP) 
Pyridoxal-5’-phosphate (PLP) 
Heme-group 
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1.2.3 Endogenous H2S role in cardiovascular system 
 
Hydrogen sulphide is a new gaseous mediator involved in both physiological 
and pathological processes in many mammalian tissues and the latest studies have 
shown a wide range of processes where it plays a regulatory role. 
One of the first finding published in literature is the relaxant effect on 
vasculature exerted by H2S, consisting in a decrease in tension in vitro and a transient 
fall in systolic blood pressure in vivo (Zhao W et al., 2001). This relaxant effect was 
reproducible in some vascular districts such as mesenteric artery, aorta and portal vein 
and importantly, the concentration of H2S needed for obtaining the relaxing effect was 
quite lower in mesenteric artery rather than the latter two (EC50: 25.2±3.6 µM for rat 
mesenteric artery; EC50: 125.0±14 µM for rat aorta) (Cheng Y et al., 2004). Some 
earlier studies showed that neither endothelial denudation nor vascular denervation 
affected hydrogen sulphide-mediated vasorelaxation, suggesting a prominent role of 
smooth muscle cells in this process. However, subsequent and more detailed studies 
revealed that both NOS inhibitors and endothelial removal shifted the dose-response 
curve to the right side, i.e. higher EC50, without affect the maximum response (Zhao W 
et al., 2002). In 1997 Hosoki R et al. showed a possible role of nitric oxide in H2S 
induced vasodilation; in particular, they showed that relaxant effect of NO was 
increased in presence of hydrogen sulphide, although there was no apparent explication 
about mechanism through which H2S exerted its effect. But in 2001, Zhao’s research 
group described ATP-dependent potassium channel (K+ATP) as the target for molecular 
action of hydrogen sulphide. In fact, using glibenclamide, a specific K+ATP channels 
blocker, the vasorelaxant effect of H2S was reverted, even if not completely abrogated. 
However, if this is the only molecular target for its action is to be further investigated. 
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As previously said, H2S effects in vascular system are not only dealing with 
physiological environment, but there are some evidences suggesting a role for this 
endogenous mediator in many pathologies, other than in cardiovascular. 
One of the pathological conditions involving H2S levels impairment is 
represented by hypertension. This condition has a multifactorial aetiology since that the 
actors playing on the stage of vascular homeostasis regulation are several and one of the 
most important is for sure represented by NO. In fact, its reduced availability is mainly 
responsible of the increase in systolic blood pressure, even if sometimes this is only an 
effect and not properly the cause generating hypertensive conditions (Busse R et al., 
1999). 
In the same way, H2S levels are reduced in plasma of two animal models of 
hypertension, such as treatment with L-ωNitro-Arginine Methylester (L-NAME), a well 
known NOS inhibitor, and Spontaneous Hypertensive Rats (SHR). In particular, 
reduction in H2S amount has been related to the downregulation of CSE mRNA 
expression and of its enzymatic activity (Zhong G et al., 2003; Yan H et al., 2004). 
Moreover, daily administration of CSE inhibitor D,L-propargylglycine (PAG) for a 
sustained time, i.e. 2-3 weeks, induces an elevation in systolic blood pressure in rats 
(Zhao W et al., 2003).  
All these are good evidences supporting a clear involvement of hydrogen 
sulphide in regulation of vascular tone, even if the poor amount of clinical studies on 
the H2S role in cardiovascular pathologies do not allow convincing conclusions. 
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1.2.4 Involvement of H2S in inflammatory processes 
 
 Inflammation is a simple word hiding a very complex meaning. It is 
characterized by a massive amount of reactions and processes having the role of 
preserving the whole body functions. In general, inflammation occurs when a tissue 
damage is originated by several types of injuries, such as pathogen, irritant or 
mechanical stimuli. Moreover, it represents the starting point of healing process.  
 The first system triggering inflammatory reaction is the endothelium, which 
changes its features and starts to counteract the injury. The primary step is represented 
by release of preformed mediators, such as bradikinin (BK), histamine (H) and 
serotonin (5-HT) and leads to swelling, redness, pain, heat, and loss of function, all 
typical for inflammation. Blood vessels also permit the extravasation of leukocytes 
through the endothelium and basement membrane constituting the blood vessel. Once in 
the tissue, the cells migrate along a chemotactic gradient to reach the site of injury, 
where they can attempt to remove the stimulus and repair the tissue. The first cells to 
reach inflammation site are neutrophils, followed by macrophages. In addition, i-NOS-
derived NO and COX-2-derived prostaglandins play a major role in maintaining of 
inflammatory state. 
Recently, many studies were published on the involvement of hydrogen sulphide 
in inflammatory events, although there is not a clear evidence for pro- or anti-
inflammatory role of H2S. Hui et al., have demonstrated that H2S levels were increased 
during septic shock in rats (Hui Y et al., 2003) and the same evidence has been shown 
in haemorrhagic shock conditions (Mok YY et al., 2004). Furthermore, H2S inhibited 
chemotaxis and degranulation of polymorphonuclear leukocytes (PMN) and their 
adhesion to endothelium (Mariggiò MA et al., 1997; Zanardo RC et al., 2006). Several 
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subsequent studies confirmed that plasma H2S concentration as well as CSE expression 
and activity were increased in LPS-treated mice (Li L et al., 2005). On the other hand, at 
least one study showed that inhibitor of H2S synthesis propargylglycine (PAG) was able 
to reduce carragenaan-induced edema in mice paws (Bhatia M et al., 2005). This 
emerging discrepancy has not been clarified as yet and  may be it is due to a different 
behaviour of H2S in various tissues and at different concentrations. 
 
 
1.2.5 How does H2S behave in other tissues ? 
 
 As previously said, hydrogen sulphide is not only involved in vascular system 
and inflammation, but there are some scientific evidences showing important role for it 
in many other tissues. 
 The presence of H2S and enzymes responsible for its synthesis have been largely 
detected in the nervous system, where the contribution of CBS seems to be predominant 
(Eto K et al., 2002). In particular, H2S enhances NMDA-induced currents and increases 
the sensitivity of NMDA receptors to glutamate in cAMP-dependent manner (Kimura 
H, 2002). In addition, H2S donors are able to decrease potassium-stimulated release of 
corticotropin release hormone (CRH) in rat hypothalamus (Dello Russo C et al., 2000). 
 Moreover, another source of endogenous H2S is represented by the 
gastrointestinal system, where both CBS and CSE are markedly expressed. In this 
particular environment, H2S seems to be a protective factor against gastric mucosa 
injury. In particular it has been shown that NaHS, a H2S donor, prevents the reduction 
of mucosal blood low originated by NSAIDs (Fiorucci S et al., 2005 a). But H2S effect 
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is also visible in isolated tissues, such as ileum, where it reduces both spontaneous and 
Ach-induced contractility (Teague B et al., 2002; Hosoki R et al., 1997). 
 Other effects for “the new gasotransmitter” have been identified in liver, where 
it contributes to relaxation of hepatic microvessels. It has been shown that in cirrhotic 
animals there is an increase in vascular resistance, likely related to a reduced expression 
in CSE and endogenous H2S production (Fiorucci S et al., 2005 b).  
These scientific evidences show that H2S signalling is widely involved in many 
cellular pathways and more likely, many other implications are so far to be discovered.  
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1.3 SCIENTIFIC BASIS AND AIM OF THE STUDY 
 
The role of hydrogen sulphide is still poorly understood although a large amount 
of studies has been already published. Furthermore the majority of experiments 
performed showed that endothelium seems do not have a key role in H2S induced effect, 
since experiments performed in endothelium-denuded tissues do not highlight any 
significant difference in H2S-induced vasorelaxation. It has to be underlined that 
mechanical endothelium removal is not necessarily reflecting the pathological condition 
known as endothelial dysfunction. Indeed, the alteration of endothelium functionality is 
a gradual and progressive process and cannot be directly related only to a  endothelium 
disruption. For this reason, in the first part of this study we focussed on the role of 
endothelium in vasorelaxant effect generated by H2S, by using Non Obese Diabetic 
(NOD) mice. This strain spontaneously and gradually develops type I diabetes 
associated to a progressive and gradual endothelial dysfunction (Bucci M et al, 2004). 
Since the role of endothelium was demonstrated to be critical by our findings, in 
the second part of this study we focussed our attention on the ability of H2S in 
modulating inflammatory events. In order to assess how this gasotransmitter could 
interfere with pathophysiological response to injuries, we used different approaches; 
first, we performed experiment of cell migration in animal model such as carragenaan-
induced paw oedema and air-pouch model, in parallel with intravital microscopy (IVM) 
studies. Then, we used a cellular and molecular approach in order to identify a mediator 
for H2S activity. 
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2. MATERIALS AND METHODS 
2.1 H2S IN VASCULAR TONE: FUNCTIONAL AND MOLECULAR STUDIES 
 
2.1.1 Reagents 
 
 Acetylcholine (Ach), serotonin (5-HT), Nω-nitro-arginine methyl ester (L-
NAME), SQ-22,536 (SQ) and ODQ were purchased from Sigma Chemical Co. (Milano, 
Italy). Sodium hydrosulphide hydrate (NaHS) and L-Cysteine hydrochloride (L-Cys) 
were purchased from Aldrich (Milano, Italy). Kit for enzymatic measurement of glucose 
levels (Trinder reaction kit) was purchased from Bio-Gamma (Roma, Italy). 
 
 
2.1.2 Non Obese Duiabetic(NOD) and Non Obese Resistant (NOR) mice 
 
 Non obese diabetic (NOD) mice is a strain with an elevated susceptibility in 
developing type 1 diabetes (IDDM) (Makino S et al., 1980). These mice show changes 
within evolution of pathology, in particular there is an early phase characterized by a 
localization of inflammatory cells, such as T-cells and activated macrophages, around 
pancreatic islet, inducing peri-insulite (4-10 weeks of age); consequently, these cells 
infiltrate islets and initiate a progressive destruction of pancreatic β-cells, resulting in a 
drastic reduction in insulin plasma level (12-30 weeks of age). The progression of 
diabetic pathology and its clinical evidences in these animals are similar to human ones 
and are associated to vascular disorders.  
NOD mice were divided into three groups, as follows, by measurement of 
glycosuria and each group can be considered representative of different diabetic states. 
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Indeed, we can consider NOD-I group where diabetic state is not yet assessed; NOD-II 
group where we have the established pathology; NOD-III group where we find severe 
pathological conditions with all clinical manifestations of diabetes, followed by death 
for circulatory and renal complicances (Doi T et al., 1990). In aortic tissues of these 
groups, a gradual reduction of acetylcholine-induced relaxation was found and this 
correlated with a reduced availability of circulating nitric oxide (Bucci M et al., 2004). 
NOR mice were used as control mice for NOD and both strains were purchased 
from Charles River Laboratories (Lecco, Italy) and then housed in an animal care 
facility. 
 
2.1.3 Determination of glycosuria 
 
Diabetic state was assessed by measurement of glycosuria. Animals were 
deprived of food for 2 hours to normalize glucose plasma levels and then put in 
metabolic cages for 4 hours, where urine samples were collected. Glycosuria levels 
were measured by glucose-6-oxidase colorimetric assay (Trinder reaction kit). 
According to glucose determination, mice were divided into three group, NOD-I (0 
mg/dl<[glucose]<20 mg/dl), NOD-II (20 mg/dl<[glucose]<500 mg/dl), NOD-III 
([glucose]>500 mg/dl), and sacrificed at different state of pathology, as described in 
following paragraph (fig. 2.1). 
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Fig 2.1 Determination of glycosuria in NOD 
mice. NOD mice show a progressive increase 
of urinary glucose levels that parallels the age. 
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2.1.4 Tissue preparation and experimental protocol 
 
NOD mice diabetic state was monitored each week by measurement of 
glycosuria (gly). NOD animals were sacrificed at different state of pathology with age-
matched NOR mice and aortas were explanted, cut in rings and used for functional 
study in isolated organ bath filled with oxygenated Krebs’ Solution at 37°C, linked to 
isometric force transducers (Fort 10, World Precision Instrument, Ugo Basile, Italy). 
Krebs’ composition was the following (mM): NaCl 118, KCl 4.7, MgSO4 1.2, KH2PO4 
1.2, CaCl2 2.5, NaHCO3 25 and glucose 11. Rings were stretched until a resting tension 
of 1.5g was reached and allowed to equilibrate for at least 45 minutes during which 
tension was adjusted, when necessary, to 1.5g and bathing solution was periodically 
changed. In a preliminary study a resting tension of 1.5g was found to develop optimal 
tension to stimulation with contracting agents. 
In each set of experiment rings were firstly challenged with serotonin (5-HT) 
(1µM) until the responses were reproducible. In order to verify endothelium integrity, 
acetylcholine cumulative concentration-response curve (10nM-30µM) was performed 
on 5-HT-precontracted rings. In this study we used both NaHS and L-Cys as source of 
H2S, a direct H2S donor and the physiological metabolic precursor respectively. In 
particular, H2S release from L-Cys is correlated to enzymatic action of both CBS and 
CSE in examined tissues. Indeed, NaHS and L-Cys cumulative concentration-response 
curves were performed on 5-HT-precontracted rings both in presence and following  
removal of vascular endothelium. 
A preliminary study on the optimal incubation time of the drug treatments and 
concentration was carried out (data not shown). L-NAME (100µM), SQ (100µM) and 
ODQ (5µM) were added in the organ baths on 5-HT-precontracted rings. After 15 
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minutes of incubation cumulative concentration-response curves to NaHS and L-Cys 
were performed. 
 
 
2.1.5 Cell experiments with normal and high glucose environment 
 
Bovine aortic endothelial cells (BAEC) were obtained by Istituto Nazionale per 
lo Studio e la Cura dei Tumori (Milano, Italy). The cells were cultured in 60mm Petri 
plastic dishes (FALCON, Microtech, Italy) and grown in medium (GIBCO, Invitrogen 
Corporation) supplemented with 2mmol/l glutamine (GIBCO), 10% heat inactivated 
fetal calf serum (GIBCO), 50U/ml penicillin, 50U/ml streptomycin. The Petri dishes 
were incubated at 37°C in a 5%CO2-95% air gas mixture. BAEC were subcultered on 
reaching confluence by use of 0.01% trypsin-EDTA. The cells were used between 
passage 5 and 6. Cells were grown until they reached 90% confluence and then were 
serum starved overnight. BAEC were pretreated for 3h with 11.5mM D-glucose 
solution (normal glucose) or 25mM D-glucose solution (high glucose) and H2S 
production was examined. 
 
 
2.1.6 Measurement of H2S: plasma and tissues 
 
Tissue H2S production rate was measured according Stipanuk method with 
modifications (Stipanuk MH & Beck PW, 1982). Briefly, aortas were homogenised in a 
lysis buffer (potassium phosphate buffer 100mM pH=7.4, sodium orthovanadate 10mM 
and proteases inhibitors). Protein concentration was determined using Bradford assay 
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(Bio-Rad Laboratories, Milano, Italy). Homogenates were added to a reaction mixture 
(total volume 500µl) containing piridoxal-5’-phosphate (2mM, 20µl), L-Cysteine 
(10mM, 20µl) and saline (30µl). The reaction was performed in parafilmed eppendorf 
tubes and initiated by transferring tubes from ice to a water bath at 37°C. After 
incubation of 40 minutes, ZnAc (1%, 250µl) was added followed by TCA (10%, 
250µl). Subsequently, DPD (20mM, 133µl) in 7.2M HCl and FeCl3 (30mM, 133µl) in 
1.2M HCl were added and absorbance of solution was measured after 20 minutes at a 
wavelength of 650nm. All samples were assayed in duplicate and H2S concentration 
was calculated against a calibration curve of NaHS (3.12-250µM). To determine basal 
release of H2S, L-Cys was not added to reaction mixture. Results were expressed as 
nmol per milligram of protein. 
Plasma determination of H2S was performed as following: 100µl of samples 
were added in eppendorf tubes containing ZnAc (1%, 150µl) and after TCA (10%, 
300µl) was added. Subsequently, DPD (20mM, 100µl) in 7.2M HCl and FeCl3 (30mM, 
133µl) in 1.2M HCl were added to reaction mixture and determination follows the same 
protocol that is described above. 
 
 
2.1.7 CSE and CBS expression: qRT-PCR 
 
Quantization of the expression level of selected genes was performed by 
quantitative real-time polymerase chain reaction (qRT-PCR). Total RNA was isolated 
with TRIzol reagent (Invitrogen, Carlsbad, CA) from mouse aortic rings.  One µg 
RNA was incubated with DNaseI (Invitrogen, Carlsbad, CA) for 15 min at room 
temperature followed by 95°C for 5 min in the presence of 2.5 mM EDTA.  The RNA 
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was reverse-transcribed with Superscript III (Invitrogen, Carlsbad, CA) with random-
primers in volume of 20 µl.  For real-time PCR, 10 ng template was used in a 25 µl 
reaction containing 0.3 µM each primer and 12.5 µl of 2X DyNAmo SYBR Green 
qPCR Kits (Finnzymes, Espoo, Finland). 
All reactions were performed in triplicate using the following cycling 
conditions: 10 min at 95 °C, followed by 50 cycles of 95 °C for 10 sec, 60 °C for 20 
sec and 72 °C for 20 sec, using an iCycler iQ instrument (Biorad, Hercules, CA). The 
mean value of the replicates for each sample was calculated and expressed as cycle 
threshold (CT: cycle number at which each PCR reaction reaches a predetermined 
fluorescence threshold, set within the linear range of all reactions). The amount of 
gene expression was then calculated as the difference (∆CT) between the CT value of 
the sample for the target gene and the mean CT value of that sample for the 
endogenous control (GAPDH).  Relative expression was calculated as the difference 
(∆∆CT) between the ∆CT values of the test and control samples for each target gene. 
The relative level of expression was measured as 2-∆∆CT. All PCR primers were 
designed using the software PRIMER3-OUTPUT using published sequence data 
obtained from the NCBI database. 
Mouse primers were as follows: CBS: (FWD) agaagtgccctggctgtaaa  and 
(REV) caggactgtcgggatgaagt; CSE: (FWD) tgctgccaccattacgatta and (REV) 
gatgccaccctcctgaagta; GAPDH: (FWD) ctgagtatgtcgtggagtctac and (REV) 
gttggtggtgcaggatgcattg. 
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2.1.8 Western blot analysis 
 
Aortic tissue or BAEC were homogenized in modified RIPA buffer (Tris-HCl 
50mM, pH 7.4, Triton  1%, Na-deoxycolate 0.25%, NaCl 150mM, EDTA 1mM, 
PMSF 1mmol/L, aprotinin 10µg/ml, Leupeptin 20µmol/L, NaF 50mmol/L) using a 
Polytron homogenizer (2 cycles of 10 seconds at maximum speed). After 
centrifugation of homogenates at 10000 rpm for 10 minutes, 10, 30 µg of the 
denatured proteins were separated on 10% sodium dodecyl sulfate polyacrylamide gels 
and transferred to a PVDF membrane. Membranes were blocked by incubation in PBS 
containing 0.1% v/v Tween 20 and 5% non-fat dry milk for 2h, followed by overnight 
incubation at 4°C with mouse polyclonal CBS (Abnova Novus Biologicals, Littleton, 
USA) antibody (1:500) or mouse monoclonal CSE (Abnova Novus Biologicals, 
Littleton, USA) antibody (1:500). The filters were washed extensively in PBS 
containing 0.1% v/v Tween 20, before incubation for 2h with anti-horseradish 
peroxidase-conjugate secondary antibody. Membranes were then washed and 
developed using Enhanced Chemiluminescence Substrate (ECL, Amersham 
Pharmacia Biotech, San Diego, CA, USA). 
 
 
2.1.9 Statistical analysis 
 
All data were expressed as mean ± s.e. mean. Statistical analysis was performed 
by using one-way ANOVA, two-way ANOVA and unpaired Student’s t-test with 
Bonferroni’s and Dunnet’s post test where appropriate. Difference were considered 
statistically significant when P was less than 0.05. 
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2.2 H2S AND INFLAMMATION: FUNCTIONAL STUDY 
 
2.2.1 Reagents 
 
Unless otherwise stated, all drugs were suspended in 1% 
carboxymethylcellulose. Aspirin, diclofenac sodium, N-formyl-Met-Leu-Phe (fMLP), 
glibenclamide, propragylglycine (PAG), β-cyanoalanine (BCA), λ-carrageenan, NaHS, 
Na2S, pinacidil, N-acetylcysteine and Lawesson’s reagent (2,4-bis(4-methoxyphenyl)-
1,3,2,4-dithiadiphosphetane 2,4-disulfide) were purchased from Sigma Chemical Co. 
(St. Louis, MO, USA). 
 
 
2.2.2 Animals 
 
 Male Wistar rats weighing 175–200 g were obtained from Charles River 
Breeding Farms (Montreal, Canada, and Monza, Italy). For 18 h prior to an experiment, 
the rats were deprived of food, but not water. All experimental procedures described 
below were approved by the institutional animal care committees and were performed in 
accordance with the guidelines of the National Council on Animal Care. 
 
 
2.2.3 Intravital  microscopy 
 
 Examination of leukocyte-endothelial interactions in vivo was performed as 
described in detail (Wallace JL et al., 1993). Postcapillary mesenteric venules with a 
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length of at least 150 µm and diameters ranging from 25 to 40 µm were selected for the 
study. A video camera mounted on the microscope (Panasonic digital 5000) projected 
the image onto a monitor, and the images were 
recorded for playback analysis using a videocassette recorder. Images of the mesenteric 
microcirculation were recorded over 5 min periods starting immediately before 
(baseline) and after aspirin administration or initiation of fMLP superfusion, and at 15 
min intervals thereafter for 60 min. Aspirin was administered intragastrically at a dose 
of 50 mg/kg, whereas fMLP (10 µM) was dissolved in the buffer that superfused the 
mesenteric venules. In controls, vehicle (1% CMC) was given intragastrically instead of 
aspirin and vessels were superfused with buffer not containing fMLP. 
Leukocyte adhesion was blindly quantified as the number of leukocytes that 
adhered to the vessel wall for at least 30 s per 100 µm venule length. Rolling leukocytes 
were defined as white blood cells moving at a velocity less than that of the erythrocytes 
in the same stream. The rolling leukocyte velocity was determined by the time required 
for a leukocyte to traverse a given distance along the length of a venule. 
To assess the effects of H2S on aspirin- and fMLP-induced leukocyte adherence, 
rats were pretreated intragastrically with Na2S (1–100 µmol/kg), NaHS (100 µmol/kg), 
or Lawesson’s reagent (0.1 to 3 µmol/kg) 30 min before aspirin or fMLP administration. 
Control rats received vehicle at the same time. In another group of experiments, 
glibenclamide was given 1 h prior to Na2S or vehicle. In other experiments, rats were 
given a reversible inhibitor of CSE (β-cyanoalanine, 50 mg/kg i.p.) 1 h prior to aspirin. 
This dose of β -cyanoalanine (BCA) has been shown to significantly inhibit CSE 
activity in the rat (Mok YY et al., 2004). 
 
 
 - 51 -
2.2.4 Paw edema 
 
Carrageenan (100 µl of a 1% w/v solution, prepared in sterile saline) was 
injected into a hind footpad of rats under halothane anesthesia. Paw volume was 
measured prior to any treatment, immediately before carrageenan administration, and at 
intervals of 1 h for 5 h thereafter using a Ugo Basile Model 7140 plethysmometer 
(Comerio, Italy). The person performing these measurements was unaware of the 
treatments the rats had received. Groups of at least 5 rats each were treated 
intraperitoneally 30 min before carrageenan administration with an H2S donor (NaHS at 
25–150 µmol/kg or Na2S at 100 µmol/kg), an NSAID as positive control (diclofenac, 10 
mg/kg), or a KATP channel agonist (pinacidil, 10 mg/kg). Other rats received BCA (50 
mg/kg i.p.) 30 min before carrageenan administration. Additional experiments were 
performed in which groups of 5 rats each received glibenclamide (10 mg/kg) or vehicle 
(dimethyl sulfoxide) i.p. 30 min before administration of one of the H2S donors. 
 
2.2.5 Statistical analysis 
 
All data were expressed as mean ± s.e. mean. Statistical analysis was performed 
by using one-way ANOVA, two-way ANOVA and unpaired Student’s t-test with 
Bonferroni’s and Dunnet’s post test where appropriate. Difference were considered 
statistically significant when P was less than 0.05. 
 
 - 52 -
2.3 H2S AND INFLAMMATION: MOLECULAR STUDY 
 
2.3.1 Human neutrophils isolation and AnxA1 mobilization analysis by western blot 
 
Human neutrophils were used in order to assess H2S influence on cytosolic 
AnxA1 mobilization. Briefly, human blood was collected from healthy volunteers in 
presence of  3,6% of sodium citrate as anticoagulant and diluted (1:1) in RPMI-1640 
(Sigma, Poole, UK). Then, it was centrifuged in Hystopaque gradient (Hystopaque 1119 
Hystopaque 1077, Sigma, Poole, UK) at 1200 rpm for 30 minutes. Neutrophils fraction 
was then gently collected and erythrocytes removed by hypotonic lysis. Cells were 
washed and then resuspended in RPMI and plated for the experiment, performed 
through the treatment of neutrophils with NaHS (0.1 and 1 mM for 30 minutes, at 
37°C). At the end of experiment, cells were spinned down and supernatants collected. 
Then, they were lysed in TRIS-HCl based lysis buffer added with proteases and 
phosphatases inhibitors, and then processed in order to separate cytosolic fraction from 
membrane fraction.  
Western blot analysis was performed using 20 µg of the denatured proteins 
(cytosolic, membrane and supernatant fractions), separated on 10% sodium dodecyl 
sulfate polyacrylamide gels and transferred to a PVDF membrane. Membranes were 
blocked by incubation in TBS containing 0.1% v/v Tween 20 (TBST) and 5% non-fat 
dry milk for 2h, followed by overnight incubation at 4°C with mouse monoclonal anti-
AnxA1 antibody (1:1000). The filters were washed extensively in TBST, before 
incubation for 2h with horseradish peroxidase-conjugate anti-mouse antibody. 
Membranes were then washed and developed using Enhanced Chemiluminescence 
Substrate (ECL, Amersham Pharmacia Biotech, San Diego, CA, USA). AnxA1 
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antibody was raised in our lab through specific column purification of serum of mice 
treated with AnxA1. 
 
2.3.2 Animals and BMD macrophages (BMDM) 
 
 Anx-A1-/- (KO) and wild-type littermate control (Anx-A1+/+) (WT) mice were 
bred in-house (Hannon et al., 2003). All animals were fed on a standard chow pellet diet 
with free access to water and maintained on a 12-h light–dark cycle. Animal work was 
performed in accordance with U.K. Home Office regulations, Animals (Scientific 
Procedures) Act 1986. Mice 4–6 weeks old were killed, the femur was excised, and the 
epiphyses removed prior to flushing out the bone marrow. Cells were washed and re-
suspended in RPMI 1640 supplemented with 25mM HEPES pH 7.4, 10% foetal calf 
serum (FCS) and 15% L929 cell-conditioned media and cells were incubated at 37°C in 
an atmosphere of 5% CO2 and 95% air for 7 days. On day 7, BMDM cultures were 
detached with PBS and plated in appropriate dishes for each assay. BMDM were then 
treated with LPS 10mg/ml, 6h and NaHS 100µM, 1h before LPS treatment. 
 
 
2.3.3 qRT-PCR on AnxA1 KO mice 
 
Real time PCR was performed on tissues harvested from Anx-A1+/+ (WT) and 
Anx-A1-/- (KO). Quantization of the expression level of selected genes (CBS, CSE, 
COX-2, i-NOS) was performed by quantitative real-time polymerase chain reaction 
(qRT-PCR). Total RNA was isolated with TRIzol reagent (Invitrogen, Carlsbad, CA) 
from cells and mouse tissues.  Extracted RNA was incubated with DNA-free Kit 
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(Ambion Inc, Europe) for 30 min at 37°C.  The RNA was reverse-transcribed with 
Superscript III (Invitrogen, Carlsbad, CA) with random-primers in volume of 20 µl. 
For real-time PCR, 40 ng of template were used in a 10 µl reaction containing 1µl of 
cDNA, 9µl of ABgene Mastermix and 1µl of specific QuantiTect Primer assay 
(Qiagen). 
All reactions were performed in triplicate using the following cycling 
conditions: 10 min at 94 °C, followed by 40 cycles of 94 °C for 15 sec, 55 °C for 30 sec 
and 72 °C for 30 sec, using an ABI PRISM-7900HT (Applied Biosystem, CA, USA). 
The mean value of the replicates for each sample was calculated and expressed as cycle 
threshold (CT: cycle number at which each PCR reaction reaches a predetermined 
fluorescence threshold, set within the linear range of all reactions). The amount of gene 
expression was then calculated as the difference (∆CT) between the CT value of the 
sample for the target gene and the mean CT value of that sample for the endogenous 
control (GAPDH). Relative expression was calculated as the difference (∆∆CT) between 
the ∆CT values of the test and control samples for each target gene. The relative level of 
expression was measured as 2-∆∆CT. 
 
 
2.3.3 Statistical analysis 
 
All data were expressed as mean ± s.e. mean. Statistical analysis was performed 
by using one-way ANOVA, two-way ANOVA and unpaired Student’s t-test with 
Bonferroni’s and Dunnet’s post test where appropriate. qRT-PCR were analysed by 
using REST© software analysis system (Pfaffl MW et al., 2002). Difference were 
considered statistically significant when P was less than 0.05. 
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CHAPTER 3 
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3. RESULTS 
3.1 H2S AND VASCULAR SYSTEM: SIGNALLING IN REGULATING 
VASCULAR TONE 
 
3.1.1 Effect of NaHS and L-Cysteine on aortic rings harvested from NOR or NOD mice 
 
NaHS (1µM-3mM) induced a concentration-dependent vasorelaxation of aortic 
rings harvested from NOR mice (fig 2A). NaHS-induced vasorelaxation was not 
affected by L-NAME pre-treatment (100µM) (fig. 2A). In NOD I and NOD II the 
relaxant response induced by NaHS on isolated aorta is not significantly different from 
NOR (fig. 2C), while in NOD III mice, where the pathology is well established and the 
endothelium is severely damaged, NaHS does induce a significant increase in  
vasorelaxation (p<0.01 vs NOR) (fig. 2C). 
Addition of L-Cysteine  (1µM-3mM) induced a relaxant effect on NOR mice 
aortic tissues (fig. 2B). L-NAME significantly inhibited L-Cysteine induced relaxation 
(fig. 2B). The disease progression leads to a significant decrease in L-cysteine-induced 
vasodilatation of aortic rings harvested from NOD II (p<0.05 vs NOR) or NOD III 
(p<0.01 vs NOR) (fig. 2D).. 
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Fig 3.1 a) H2S-induced vasorelaxation in aortic rings harvested from NOR or NOD mice. 
L-NAME pre-treatment does not affect NaHS-induced vasorelaxation in NOR mice. b) 
NaHS-induced vasorelaxation is enhanced in NOD-III mice (p<0.01 vs NOR) 
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Fig 3.2 a) . L-NAME pre-treatment affected L-cysteine-induced vasorelaxation in NOR 
mice (*** p<0.001 vs vehicle). b) L-cysteine-induced vasodilatation was gradually reduced 
in NOD mice (D); (** p<0.01 vs NOR; *** p<0.001 vs NOR) 
a) 
b) 
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3.1.2 Contribution  of cAMP and cGMP  in H2S-induced vasorelaxation 
 
In order to evaluate a possible involvement of cAMP and cGMP we tested the 
effect of ODQ, a NO-sensitive guanylate cyclase inhibitor or SQ-22,536 an adenylate 
cyclase inhibitor, on H2S-induced vasorelaxation. Incubation of NOR aortic rings with 
ODQ at the concentration of 5µM almost abrogated L-Cysteine-induced relaxation (fig. 
3A). Conversely SQ (100µM) did not affect L-Cysteine-induced relaxation (fig. 3A).  
A similar pattern of inhibition was obtained with  NODII and NOD III mice 
aortas. In particular L-cysteine-induced vasorelaxation, already impaired in NOD III 
mice, was abrogated by pre-treatment with ODQ, but unaffected by SQ-22,536 (fig. 
3B). Neither ODQ or SQ affected NaHS-induced vasorelaxation in both NOR or NOD 
mice (data not shown). 
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Fig 3.3 Effect of ODQ and SQ-22,536 on L-cysteine-induced vasorelaxation. ODQ 
(5µM, 15 minutes) significantly inhibited L-cysteine vasorelaxant response both in 
NOR (a) and NOD-III (b) mice (*** p<0.001 vs vehicle) 
a) b) 
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3.2 H2S AND VASCULAR SYSTEM:  RELEASE AND MOLECULAR CHANGES 
IN PRODUCTION 
 
3.2.1 Impairment of CBS/CSE activity in NOD mice 
 
Plasmatic concentration of H2S was between 50-65µM in NOR mice. In NOD 
III mice there was a 50% reduction in H2S levels (fig. 4A; ** p<0.01 vs NOR). To 
assess if the systemic H2S impaired production was reflected by an analogue 
dysfunction at vascular level we evaluated the basal and the L-cysteine stimulated 
release of H2S in aortic rings harvested by NOR and NOD mice. The basal production 
of H2S in NOD mice aortas was not significantly reduced if compared to NOR mice 
aortas (figure 4B). Conversely, the conversion of exogenous L-cysteine to H2S was 
significantly impaired in aorta harvested from NOD II and NOD III mice (* p<0.05; *** 
p<0.001; stimulated vs basal; # p<0.05; ## p<0.01 vs NOR). Although H2S levels 
resulted progressively lowered during diabetes progression, both western blot (fig. 5A) 
and qRT-PCR (fig. 5B) showed a significant upregulation of both CBS and CSE in 
vessels harvested by NOD II and NOD III mice. 
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Fig 3.4 H2S plasmatic levels were 
significantly reduced in NOD-III mice 
(** p<0.01 vs NOR; n=5) 
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Fig 3.5 a) Tissue H2S levels (basal) were not different in NOR and NOD mice, while H2S production 
following L-cysteine challenge (stimulated) was significantly reduced in aorta harvested from NOD I or 
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3.2.2 High glucose environment affects stimulated H2S production  in BAEC 
 
Western blot analysis showed that BAEC express CBS but not CSE. To assess 
the specific role of endothelial cells we exposed BAEC to normal or high glucose 
environment using a well established protocol (26). In normal glucose medium we 
detected value of H2S of ∼70nmol/mg protein min-1, whereas on stimulation with L-
cysteine we measured values of H2S of ∼170nmol/mg protein min-1 with a 60% of 
increase in the response. When cells are cultured in high glucose medium, the 
unstimulated value was not affected, whereas L-cysteine-induced release was 
significantly reduced  (fig. 6; * p<0.05 stimulated vs basal). 
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Fig 3.6 Evaluation of H2S production in BAEC. a) Western blot analysis showed a specific 
expression of CBS in BAEC. b) When BAEC were cultured in high glucose medium, basal H2S 
production value was not affected, whereas L-cysteine-stimulated release of H2S was 
significantly reduced (* p<0.05 vs basal) 
a) 
b) 
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3.3 H2S AND INFLAMMATION:  
 
3.3.1 H2S donors decrease ASA-induced leukocyte adhesion through the activation of 
KATP channels 
 
Oral administration of aspirin (50 mg/kg) induced a significant time-dependent 
increase in leukocyte adherence compared with rats that received vehicle (fig. 3.7). 
Pretreatment of rats with Na2S dose-dependently decreased aspirin-induced leukocyte 
adherence to the mesenteric microcirculation (ED50: 5.0 µmol/kg). The reduction of 
leukocyte adherence by Na2S likely occurred through activation of K+ATP channels, 
since pretreatment with an antagonist of those channels, glibenclamide, reversed the 
effects of the H2S donor. Glibenclamide given to rats prior to vehicle or ASA did not 
alter basal leukocyte adherence or that induced by aspirin (data not shown). NaHS (100 
µmol/kg) also inhibited aspirin-induced leukocyte adherence.  
 
Fig 3.7 Hydrogen sulfide inhibits aspirin induced leukocyte adherence in mesenteric venules through 
activation of K+ATP channels. Na2S dose-dependently suppressed leukocyte adherence induced by  
intragastric aspirin (50mg/kg). The inhibition of aspirin-induced adherence by Na2S (100 µmol/kg) was 
abolished by pretreatment with glibenclamide (10 mg/kg), a K+ATP channel antagonist. *P<0.05 vs. the 
corresponding vehicle-treated group. ψP< 0.05 vs. the corresponding group receiving aspirin alone. 
Data are expressed as mean ± SEM, n=5. 
 - 64 -
3.3.2.H2S donors inhibit fMLP-induced leukocyte adherence 
 
Pretreatment with Na2S or NaHS (each at 100 µmol/kg) abolished fMLP-
induced leukocyte adherence to the mesenteric microcirculation (fig. 3.8). Lawesson’s 
reagent also inhibited leukocyte adhesion when administered at a dose of 1 µmol/kg. At 
a dose of 0.3 µmol/kg, Lawesson’s reagent did not affect fMLP-induced leukocyte 
adherence (data not shown). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 3.8 Hydrogen sulfide inhibits fMLP-induced leukocyte adherence in mesenteric venules. Superfusion of 
the vessels with N-formylated-Met-Leu-Phe (fMLP; 10µM) induced a time-dependent increase in leukocyte 
adherence. Hydrogen sulfide donors, given 30 min before fMLP, suppressed the increase in leukocyte 
adherence to levels not significantly different from control levels of adherence (*P<0.05 vs. the group 
receiving vehicle in place of fMLP). Na2S and NaHS were given at 100 µmol/kg, and Lawesson’s reagent 
was given at 1 µmol/kg. The results are plotted as mean ± SEM, n=5. 
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3.3.3 H2S modulates oedema formation via effects on KATP channels 
 
Injection of carrageenan into the hind footpads of rats resulted in a rapid and 
marked increase in paw volume as a consequence of edema formation (fig. 3.9a). The 
increase in paw volume could be significantly reduced by pretreatment with diclofenac 
(an NSAID). Pretreatment with NaHS or Na2S similarly decreased carrageenan-induced 
paw edema (ED50: 35 and 28 µmol/kg, respectively), as did pinacidil, a K+ATP channel 
agonist. In contrast, suppression of endogenous H2S synthesis, through administration 
of BCA, resulted in a significantly greater paw swelling response to carrageenan. The 
reduction paw edema by either of the H2S donors (NaHS or Na2S) could be reversed by 
pretreatment with glibenclamide (fig. 3.9b). 
Fig 3.9 a) Injection of carrageenan into the rat hindpaw resulted in significant oedema formation as indicated by 
the increase in paw volume. Pre-treatment with NaHS significantly reduced paw oedema (P<0.05), as pre-
treatment with diclofenac and pinacidil did. In contrast, administration of BCA significantly increased the 
oedema formation induced by carrageenan (P<0.05). b) The increase in paw oedema occurring during the first 
hour after carrageenan administration is shown. The reduction of paw oedema by both NaHS and Na2S was 
abolished by pre-treatment with glibenclamide, whereas glibenclamide alone did not alter carrageenan-induced 
oedema formation. Data are shown as mean ± SEM, n=5 
a) 
b) 
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3.3.4 H2S induced externalization of NaxA1 onto membrane surface 
  
 Neutrophils were isolated and treated with H2S donor NaHS at 0.1 and 1mM for 
30 minutes at 37°C. Western blot analysis clearly showed that AnxA1, normally 
resident in cytosolic compartment (C), mobilized towards cell membrane surface (M) 
after treatment with NaHS. In addition, NaHS also induced release of AnxA1 in 
extracellular environment (S) (fig. 3.10). 
 
 
 
 
 
 
 
 
 
 
 
 
C M S C M S C M S
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33 kDa
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Annexin-1
Fig 3.10 Western blot analysis on neutrophils isolated from peripheral human blood. Cells 
were treated and fractionated in cytosolic (C), membrane (M) and supernatant (S) fraction. 
AnxA1 is shown in two bands of 33 (cleaved) and 37 kDa (uncleaved) respectively. Blot is 
representative of three different experiments. 
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3.3.5 H2S reverted CSE, COX-2 and i-NOS over-expression in LPS treated BMDM 
through AnxA1-dependent mechanism 
 
 qRT-PCR analysis on BMDM treated with LPS showed an increase in 
expression of CSE (1.3 fold increase, *p<0.05, n=3) and a very high expression of 
COX-2 and i-NOS (14 and 7 fold increase respectively, ***p<0,001, n=3). When 
BMDM were treated with NaHS, the observed effect was the reversion of LPS-induced 
increase in expression of CSE, COX-2 and i-NOS (# p<0.05, n=3; ### p<0.001, n=3; # 
p<0.05, n=3 respectively) (fig. 3.11). Conversely, the effect of NaHS was completely 
lost when the same experiment was carried out on BMDM from AnxA1-/- mice (fig. 
3.12). These data may suggest that H2S anti-inflammatory effect could be partially due 
to activation of AnxA1 signalling. 
 
 
3.3.6 H2S production in AnxA1-/- mice 
 
 We speculated on the role of CBS and CSE in AnxA1-/- mice, performing qRT-
PCR analysis on several tissues. We found a marked increase in both CBS and CSE 
expression in the aorta of knock-out mice compared to wild-type (21 and 60 fold 
increase for CBS and CSE respectively). Similar results were observed in lymph nodes 
(LN), even if the increase in expression in AnxA1-/- mice was not comparable to the one 
found in the aorta (4 and 3 fold increase for CBS and CSE respectively). Liver, the most 
important producer of H2S, did not show any significant change in the expression of 
both enzymes between wild-type and knock-out. Conversely, in spleen and kidney we 
found an upregulation only for CBS expression (10 fold increase) (fig. 3.13). 
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Furthermore, we dosed plasmatic levels of H2S and we found that LPS induced 
an increase in H2S amount in AnxA+/+ mice compared to no-treated mice. In addition, is 
noteworthy that plasmatic levels of H2S in no-treated AnxA1-/- mice were higher than 
ones detected in no-treated AnxA1+/+ mice (fig. 3.13); these data fit with the higher 
expression of CBS and CSE in AnxA1-/- mice compared to AnxA+/+ mice. 
 In addition to these data we have also performed H2S production assay on tissues 
harvested from AnxA1+/+  and AnxA1-/- mice. We found that basal production of H2S in 
aorta was increased in LPS treated animals. On the other hand, basal H2S produced in 
non-treated AnxA1-/- mice was lowerd compared to wild-type animals. There were not 
significant differences in production of H2S in liver, fitting with data not showing any 
changes in CBS or CSE expression in liver. Conversely, in kidney we found a 
significant increase in basal production of H2S in non-treated AnxA1-/- mice compared 
with AnxA1+/+ mice (fig. 3.14). 
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Fig 3.11 qRT-PCR on BMDM isolated from AnxA1+/+ mice. NaHS pre-treatment reduces LPS-
induced overexpression of CSE (a), COX-2 (b) and i-NOS (c). (* p<0.05 vs CTR; *** p<0.001 vs 
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Fig 3.12 qRT-PCR on BMDM isolated from AnxA1-/- mice. After genetic deletion of AnxA1, 
the reducing effect of NaHS pre-treatment on expression of CSE (a), COX-2 (b) and i-NOS (c) 
after LPS treatment was lost (n=3). 
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Fig 3.13 qRT-PCR analysis  for CBS or CSE expression performed on aorta (a), liver (b), lymph 
nodes (c), spleen (d) and kidney (e) harvested from AnxA1-/- mice. Data are expressed as mean 
of fold increase ± SEM. e) Plasmatic H2S levels in AnxA1+/+ or AnxA1-/- mice under normal 
condition and after stimulation with LPS 
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Fig 3.14 H2S production in aorta (a), liver (b) and kidney (c) harvested from AnxA1+/+ and 
AnxA1-/- mice under basal condition and after exogenous L-cysteine feeding (stimulated). 
Animals were treated with LPS (10mg/Kg) and with saline (n=3). 
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4. DISCUSSION 
 
The biological relevance of hydrogen sulphide has been recently addressed by 
different research group and in many papers it has been shown that H2S participates to 
various pathophysiological conditions. 
Vascular studies have shown that H2S-induced vasorelaxation is not affected by 
endothelium removal, suggesting that endothelium is not involved in H2S pathway at 
vascular level (Zhao W et al., 2001; Wang R, 2002; Hosoki R et al., 1997). Mechanical 
endothelium removal only partially mimics the pathological condition known as 
endothelial dysfunction. Indeed, the alteration of endothelium functionality, in the 
majority of the cases, is a gradual and progressive process and cannot be simply and 
directly related to a mechanical non specific endothelium disruption. In the first part of 
this work, we used NOD mice, a strain that spontaneously and gradually develops 
diabetes associated to a progressive endothelial dysfunction, in order to assess the 
involvement of H2S pathway in an endothelial progressive disorder and a possible 
interplay with nitric oxide. 
In physiological conditions, we have found by using NOR mice tissues that 
administration of NaHS or L-cysteine, on pre-contracted aortic rings, induced a 
concentration-dependent vasorelaxation. When we blocked the NO contribute by using 
L-NAME, we found a marked inhibition of L-cysteine-induced relaxation, but not of 
NaHS. A similar pattern was observed in NOD-I mice that have normal 
glycosuria/glycaemia. Conversely, as expected, when an H2S donor is used, as 
exogenous source of the gas, there are no changes in the vasodilatory pattern. Thus, it 
appears that L-Arginine/NO pathway is involved in L-cysteine-induced vasorelaxation 
in physiological condition. 
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In pathological conditions L-cysteine-induced vasodilatation was impaired. 
Indeed, aortic vessels harvested from NOD II and NOD III mice showed a reduced 
vasodilation that paralleled the disease progression and endothelial dysfunction. As we 
have already demonstrated, NOD mice vessels display an impaired Ach-induced 
vasorelaxation strictly related to a specific and progressive disorder in eNOS post-
translational activation (Bucci M et al., 2004). Thus, in pathological conditions, where 
there is a reduced production of NO we mimicked the effect of L-NAME on normal 
rings (physiological)  further supporting the previous hypothesis that basal production 
of NO is involved in the machinery necessary for endogenous production of H2S. This 
hypothesis is further corroborated by the finding that NaHS-induced vasorelaxation was 
significantly  enhanced in NOD III mice  but unaffected in NOD I or NOD II mice. The 
enhanced response of NaHS in NOD III mice, where a strong impairment of Ach-
induced relaxation is present (Bucci M et al., 2004), could be explained by a reduced 
direct interaction (chemical quenching) between basal NO and exogenous H2S .   
Soluble guanylate cyclase is the primary target for NO, thus if the previous 
hypothesis is valid, modulation of the enzyme should in turn modulate L-cysteine 
induced response without affecting NaHS–induced vasodilatation. In order to assess this 
theory we compared the vasodilatory response elicited by either NaHS or L-cysteine 
following pharmacological modulation with either ODQ an inhibitor of soluble 
guanylate cyclase  or with SQ-22,536 an inhibitor of adenylate cyclase in NOR versus 
NOD III aortic rings. As expected incubation with ODQ or SQ-22,536 did not affect 
NaHS-induced vasorelaxation in both NOR and NOD III mice. Conversely, ODQ but 
not SQ-22,536 caused a marked inhibition of L-cysteine-induced vasorelaxation in rings 
harvested from both NOR or NOD III mice. This finding together with the previous data 
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strongly implies that endogenous H2S production through L-cysteine may be modulated 
by nitric oxide through guanylate cyclase. 
Recently, Jiang HL et al. have demonstrated a similar correlation between NO 
and H2S  in patients with coronary heart disease. Indeed, in these patients H2S levels 
decrease parallels the disease severity and is further impaired if patients were smokers 
and/or hypertensive patients as NO does (Jiang H et al., 2005). Interestingly similarly to 
NO, H2S levels are inversely correlated to glycaemia as in our experimental model. 
When we measured plasma levels we found that H2S concentration  declined following 
the disease severity as well as the glycosuria. In particular H2S levels were reduced of 
about 50% in NOD III mice. Evaluation of H2S  levels in aorta harvested from NOR, 
NOD I, NOD II or NOD III mice was similar. However,  when aorta tissues were fed 
with exogenous L-cysteine, in order to assess the ability to convert the substrate, we 
found a progressive reduction of H2S production that paralleled the disease progression. 
Overall these data suggest a role for the endothelium and in particular of endothelial 
nitric oxide  in modulating endogenous production of H2S.  
To further confirm this hypothesis we tested the direct effect of L-cysteine on 
endothelial cells by using BAEC.  Indeed, we have recently demonstrated that BAEC 
incubated in high glucose environment display an impaired NO production as well as an 
increased expression of caveolin-1, an endogenous inhibitory protein for eNOS 
activation. The same increased caveolin-1 expression coupled to impaired NO 
production was present in vessels harvested from NOD III mice (Bucci M et al., 2004). 
Administration of L-cysteine to BAEC in normal glucose environment induced an 
increase in  H2S production, confirming the ability of endothelial cells to convert L-
cysteine to H2S. When L-cysteine was fed to BAEC grown in high glucose environment 
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there was a significant decrease in H2S  production. This pattern paralleled the pattern  
found in aortic tissue harvested from NOD III mice. 
In conclusion these results show that endothelial dysfunction significantly 
impairs endogenous H2S signalling without affecting the ability of vascular tissue to 
react to exogenous H2S. Furthermore, these data suggest that endothelium has an active 
role in modulating H2S endogenous production and that the reduction in L-cysteine-
induced relaxation may be originated by the lost ability by vascular tissue in converting 
L-cysteine to H2S following eNOS impairment activity. 
This part of this work has clearly demonstrated that endothelium is one of the 
machinery involved in H2S signalling in vascular responses. Thus, we focussed our 
attention on the role of endothelium in H2S-induced response in inflammatory 
processes, since that endothelial cells have a critical role in both triggering and 
resolving phases of inflammation. 
Studies over the past 5 years have provided convincing evidence that H2S is an 
important modulator of vascular tone and acts as a neuromodulator as well (Wang R, 
2002; Abe K et al., 1996). The results coming from the second part of the present study 
suggest that H2S also plays important roles in the context of inflammation. H2S is 
generated at sites of inflammation and can influence the ability of neutrophils to cause 
tissue injury (Whiteman et al., 2004); it was recently shown to reduce visceral pain 
perception (Distrutti E et al., 2005). In the present study, we have demonstrated that 
several H2S donors can suppress leukocyte adherence to the vascular endothelium and 
can reduce leukocyte infiltration and oedema formation. These effects of H2S were seen 
irrespective of the inflammatory stimulus used (carrageenan, aspirin, fMLP). 
Suppression of endogenous H2S synthesis, through blockade of CSE, resulted in 
enhanced leukocyte adhesion, leukocyte infiltration, and oedema formation. These 
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actions appeared to be mediated via K+ATP channels, as they were reversed by pre-
treatment with glibenclamide and mimicked by pinacidil, a K+ATP channels blocker and 
a K+ATP channels opener respectively. 
Our findings therefore suggest an important role for endogenous H2S as a 
modulator of some of the key components of acute inflammatory responses, particularly 
those occurring at the leukocyte-endothelial interface. As for other gaseous mediators 
(carbon monoxide, NO), H2S was recognized for its toxicity long before its importance 
in physiological processes was described. H2S is synthesized, primarily from L-
cysteine, through actions of the enzymes CSE and CBS. In rats, blood and plasma levels 
of H2S are in the 10–100 µM range (Richardson CJ et al., 2000). In the present study, 
we used three different H2S donors at doses that would approximate concentrations of 
H2S that fall within this physiological range. Differences in the potency of Lawesson’s 
reagent vs. Na2S and NaHS in suppressing leukocyte adherence/infiltration are 
consistent with observed differences in their ability to elicit H2S-mediated vascular 
smooth muscle relaxation. Moreover, the observation that suppression of endogenous 
H2S synthesis with β-cyanoalanine led to increased leukocyte adherence and infiltration 
is consistent with a role for this mediator as a tonic inhibitor of leukocyte 
adherence/extravasation. Our observation that leukocyte rolling velocity decreased 
sharply after administration of the CSE inhibitor is consistent with previous 
observations that P-selectin expression can be regulated by H2S (Fiorucci S et al., 
2005). Since leukocyte expression/affinity of LFA-1 has also been shown to be 
suppressed by H2S (Fiorucci S et al., 2005), it is possible to hypothesize that H2S by 
modulating expression of proteins on both cell types regulates leukocyte migration. 
It has been recently reported that NSAIDs suppress H2S synthesis by reducing 
expression of CSE (Fiorucci S et al., 2005). The subsequent reduction of H2S synthesis 
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may contribute to the increase in leukocyte adherence that is seen after NSAID 
administration (Asako H et al., 1992; Wallace JL et al., 1993), which has been shown to 
contribute significantly to the gastric injury induced by this class of drugs (Wallace JL 
et al., 1990; Wallace JLet al., 1991; Wallace JL et al., 1997). Indeed, co-administration 
of an H2S donor with an NSAID resulted in inhibition of NSAID-induced leukocyte 
adherence and reduction of the severity of gastric damage (Fiorucci S et al., 2005). 
Pertinent to the present study, administration of an H2S donor prevented many of the 
other “proinflammatory” effects of NSAIDs, including the elevation of ICAM-1 and 
LFA-1 expression and the increase in mucosal TNFα expression (Fiorucci S et al., 
2005). 
Among the four H2S donors used in the second part of this study, only N-
acetylcysteine requires metabolism in order for H2S to be released. N-acetylcysteine is a 
precursor of Lcysteine (Fujii K et al., 2005), which is the substrate for H2S generation 
via CSE and/or CBS. The observation that the anti-inflammatory actions of N-
acetylcysteine were reversed by an inhibitor of CSE (β-cyanoalanine) is consistent with 
the effects being mediated by H2S. 
Irreversible inhibitors of CSE and CBS have been reported to interfere with 
other enzymes (Moore PK et al., 2003; Smith SB et al., 1977). As with any 
pharmacological agent, we cannot exclude the possibility that the reversible inhibitor of 
CSE, β-cyanoalanine, could exert non-specific effects. For these reasons we have 
developed and studied four different H2S donors in order to adderss this issue. 
Genetic deletion of CSE and CBS are lethal, ruling out the use of these 
“knockouts”. CBS heterozygotes are viable, expressing half as much CBS as wild-type 
(WT). When fed a diet high in homocysteine, CBS-/- mice have been shown to exhibit 
increased leukocyte adherence, increased P-selectin expression, and increased vascular 
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permeability (in the brain) (Kamath AF et al., 2006), all consistent with a role for H2S in 
mediating acute inflammation. However, use of these mice for direct studies of 
inflammation is of questionable value, as they have drastically altered vascular 
responsiveness to cholinergic agents and bradykinin (Weiss N et al., 2002). 
A consistent finding in the various models used in the present study was that the 
anti-inflammatory effects of H2S appeared to be mediated via activation of K+ATP 
channels. Similarly, the analgesic effect have been ascribed to modulation of K+ATP 
channels (Distrutti E et al., 2005). It is possible, therefore, that K+ATP channels represent 
a novel target for anti-inflammatory and analgesic agents. 
In addition to these data, hydrogen sulphide also plays a primary role in 
resolving phase of inflammation. In fact, our results suggest that H2S is able to induce 
an anti-inflammatory effect, likely relying on annexin-1-dependent responses, as we 
have demonstrated in our experiments performed on human neutrophils, bone marrow-
derived macrophages and AnxA1-/- mice. 
In summary, the results showed in the second part of the present study 
demonstrates a role for endogenous H2S as a modulator of key inflammatory events 
occurring at the interface of leukocytes and the vascular endothelium. H2S may act as a 
tonic regulator of leukocyte adherence to the endothelium and of endothelial 
permeability. The anti-inflammatory effects of H2S appear to be mediated via activation 
of both K+ATP channels and annexin-1. These results, and recent reports that H2S donors 
can down-regulate adhesion molecule and pro-inflammatory cytokine expression, 
therefore identify H2S, the key enzymes responsible for H2S synthesis, and K+ATP 
channels as potential targets for novel anti-inflammatory therapies. 
Finally, we can conclude that H2S is a very complex modulator in despite of a 
very simple chemical structure. 
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Indeed, it is involved in vascular homeostasis directly and also through 
interaction with L-arginine/NO pathway; most likely through K+ATP channels and 
annexin-1. 
Furthermore, the ability of endothelial cells to generate H2S is very consistent 
with the function that H2S exerts at the endothelium-blood interface. These findings 
open a new horizon in the pharmacology of the gaseous mediators. Thus, the scenario 
we have in front of us is far to be completely understood, since now there are three 
mediators, NO, H2S and CO, all contributing to the complex phenomenon of 
inflammation and still there is much to be understood on each single mediator as well as 
on the possible cross talk among them. 
Unravelling these issues will allow researchers in the future to develop new 
therapeutic targets and design new and effective drugs. 
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